| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/19/2007 | EP1670923A4 Method for mass production of human follicle stimulating hormone |
| 09/19/2007 | EP1572066A4 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 09/19/2007 | EP1407044B1 Rna interference mediating small rna molecules |
| 09/19/2007 | EP1326990B1 Packaging of positive-strand rna virus replicon particles |
| 09/19/2007 | EP1257644B1 103p2d6: tissue specific protein highly expressed in various cancers |
| 09/19/2007 | EP0714438B1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 09/19/2007 | CN101039955A Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 09/19/2007 | CN101037698A Mycobacterium tuberculosis rpfc gene and usage thereof |
| 09/19/2007 | CN101037691A CENP-E combined protein and encoding gene and application |
| 09/19/2007 | CN101037689A Anti-sense nucleotide of c-erbB2 cancer gene combined with epidermal growth factor and its application |
| 09/19/2007 | CN101037688A Small molecule interfering RNA and its anti-tumor use |
| 09/19/2007 | CN101037674A Rebuilt gland virus containing BMP-7 gene and usage thereof |
| 09/19/2007 | CN101036867A Polyethylenimine derivates nanometer hollow microspheres and the preparing method |
| 09/19/2007 | CN101036791A Mutans streptococci gene vaccines pcDNA3-pac and the preparing method |
| 09/19/2007 | CN101036790A Protein genetic vaccines on the surface of mutans streptococci and its preparing method |
| 09/19/2007 | CN101036789A RNA-interfering medicine of antineoplastic targeting focal adhesion kinase FAK |
| 09/19/2007 | CN101036730A Selenium germanium peptide jujube tea powder for curing cancer radically |
| 09/19/2007 | CN101036728A Selenium germanium peptide maggot skin antithrombotic jujube tea powder for curing encephalatrophy radically |
| 09/19/2007 | CN100338220C Liver highly expression regulating gene sequence and its application |
| 09/19/2007 | CN100338219C Tissue specific expression of retinoblastoma protein |
| 09/19/2007 | CN100338216C Antisense oligonucleotide sequence resistant to Candida albicans infection and its uses |
| 09/19/2007 | CN100338086C Immunostimulatory nucleic acid molecules |
| 09/18/2007 | USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
| 09/18/2007 | US7271886 Uncaging device |
| 09/18/2007 | US7271251 Polyclonal and, or monoclonal antibodies; immuniglobulin immunization |
| 09/18/2007 | US7271242 Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7271002 Generating adeno-associated vector particles in insects; bioreactors and heterologous gene expression |
| 09/18/2007 | US7270963 Growth differentiation factor, lefty-2 |
| 09/18/2007 | US7270821 Hepatitis B core antigen fusion proteins |
| 09/18/2007 | US7270812 Pharmaceutical composition for treatment of cancers |
| 09/18/2007 | US7270811 Recombinant replication-defective adenovirus serotypes 11, 25, 34, 35, 48 and 49 as gene delivery vehicles for gene therapy; reduced drug resistance, increased effectiveness of vaccination |
| 09/18/2007 | US7270810 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 09/18/2007 | CA2276460C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/18/2007 | CA2216919C Nanospheres comprising a biocompatible polysaccharide |
| 09/18/2007 | CA2137161C Nucleic acids and methods of use thereof for controlling viral pathogens |
| 09/16/2007 | CA2539902A1 Method of enhancing degradation of chitin |
| 09/13/2007 | WO2007104011A2 Inhibition of microtubule protrusion in cancer cells |
| 09/13/2007 | WO2007103876A2 Cancer therapeutic |
| 09/13/2007 | WO2007103825A2 Combination therapy with oncolytic adenovirus |
| 09/13/2007 | WO2007103787A2 Treatment of tendinopathy by inhibition of molecules that contribute to cartilage formation |
| 09/13/2007 | WO2007103529A2 Antisense antiviral compound and method for treating arenavirus infection |
| 09/13/2007 | WO2007103201A2 Cellular delivery of sirna |
| 09/13/2007 | WO2007103114A2 Notch inhibition in the treatment or prevention of atherosclerosis |
| 09/13/2007 | WO2007102618A1 Nucleic acid cleaving agent |
| 09/13/2007 | WO2007102581A1 2'-hydroxyl-modified ribonucleoside derivative |
| 09/13/2007 | WO2007102572A1 Inhibitor for cellular aging |
| 09/13/2007 | WO2007102481A1 Vector for nuclear transport of substance |
| 09/13/2007 | WO2007102326A1 Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 09/13/2007 | WO2007101657A1 Hepatitis c virus non structural fusion protein |
| 09/13/2007 | WO2007087367A9 Methods and compositions for modulating the mobilization of stem cells |
| 09/13/2007 | WO2007084247A9 Stable therapeutic formulations |
| 09/13/2007 | WO2007063075A1 Induction of mucosal tolerance to antigens |
| 09/13/2007 | WO2007044468A3 Method to treat flavivirus infection with sirna |
| 09/13/2007 | WO2006125141A3 A method for the treatment of pompe disease using 1-deoxynojirimycin derivatives |
| 09/13/2007 | WO2006074182A3 Growth factor therapy mobilization of stem cells into the peripheral blood |
| 09/13/2007 | WO2005040347A3 Methods and compositions for inhibiting cell growth and proliferation |
| 09/13/2007 | WO2005021716A3 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders |
| 09/13/2007 | WO2000061614A8 Uncoupling proteins |
| 09/13/2007 | US20070213293 Rnai therapeutic for respiratory virus infection |
| 09/13/2007 | US20070213292 Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| 09/13/2007 | US20070213291 Therapeutically useful synthetic oligonucleotides |
| 09/13/2007 | US20070213289 Method for purifying plasmid DNA |
| 09/13/2007 | US20070213287 Introducing nucleic acid encoding therapeutic gene product formulated with an anionic polymer selected from polyglutamic acid, polyaspartic acid, polygalacturonic acid, poly vinyl sulfate into cell |
| 09/13/2007 | US20070213286 Inhibitors of dynein or lissencephaly 1, and methods of using same for treatment of neuronal disorders |
| 09/13/2007 | US20070213274 Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C) |
| 09/13/2007 | US20070213271 Composition and method for treating hiv infection |
| 09/13/2007 | US20070213263 Methods And Compositions Using Adiponectin For Treatment Of Cardiac Disorders And For Stimulation Of Angiogenesis |
| 09/13/2007 | US20070213257 Compositions and methods for complexes of nucleic acids and peptides |
| 09/13/2007 | US20070213256 Novel genes and proteins encoded thereby |
| 09/13/2007 | US20070212779 Targeting adenoviral vectors to dendritic cells |
| 09/13/2007 | US20070212769 Transfection, culturing; electrophoresis |
| 09/13/2007 | US20070212727 Microorganisms for therapy |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212404 Liposome And Method Of Preparing The Same |
| 09/13/2007 | US20070212380 Conjugated Fatty Acid Based Emulsion and Methods for Preparing and Using Same |
| 09/13/2007 | US20070212373 Lawsonia Intracellularis 26 Kd Subunit Vaccine |
| 09/13/2007 | US20070212370 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 09/13/2007 | US20070212368 Proteins |
| 09/13/2007 | US20070212347 Compositions and methods for treating polycystic kidney disease gene |
| 09/13/2007 | US20070212341 Method for Preparing Active Kinases Containing Ph Domains |
| 09/13/2007 | US20070212338 Hybrid cells |
| 09/13/2007 | US20070212337 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| 09/13/2007 | US20070212334 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 09/13/2007 | US20070212333 Methods and compositions for the treatment of dystonia |
| 09/13/2007 | US20070212332 Methods for accelerating bone repair |
| 09/13/2007 | US20070212331 Methods and compositions for selectively killing cells |
| 09/13/2007 | CA2645177A1 Hepatitis c virus non structural fusion protein |
| 09/13/2007 | CA2644708A1 Treatment of tendinopathy by inhibition of molecules that contribute to cartilage formation |
| 09/13/2007 | CA2643951A1 Complement binding aptamers and anti-c5 agents useful in the treatment of ocular disorders |
| 09/12/2007 | EP1832663A2 Uses of DNA-PK |
| 09/12/2007 | EP1832657A1 Methylation of plasmid vectors |
| 09/12/2007 | EP1832653A1 MN gene and protein |
| 09/12/2007 | EP1832603A2 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832292A1 Treatment of neurodegenerative disease through intracranial delivery of short interfering RNA (siRNA) |
| 09/12/2007 | EP1831688A1 Methods and compositions for treating epithelial cancers |
| 09/12/2007 | EP1758614A4 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof |
| 09/12/2007 | EP1689447A4 Gene transfer for regulating smooth muscle tone |